Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 1.00 |
| ▸ | PDE4A | P27815 | 2/20 | 1.00 |
| ▸ | SNCA | P37840 | 2/20 | 1.00 |
| ▸ | PDE3A | Q14432 | 2/20 | 1.00 |
| ▸ | PGR | P06401 | 1/20 | 0.61 |
| ▸ | HTR1A | P08908 | 1/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | DRD3 | P35462 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.48 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.45 |
| ▸ | CDC25B | P30305 | 2/20 | 0.45 |
| ▸ | DHODH | Q02127 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phytonadione SCHEMBL419597 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3APGR | |
| SCHEMBL9956594 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3APGR | |
| Phytonadione SCHEMBL29845402 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3APGR | |
| SCHEMBL14379723 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3APGR | |
| Phytonadione SCHEMBL3882 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3APGR | |
| Phytonadione SCHEMBL351364 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3APGR | |
| Phytonadione SCHEMBL8710454 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3APGR | |
| Phytonadione SCHEMBL8756574 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3APGR | |
| Phytonadione SCHEMBL30144830 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3APGR | |
| Phytonadione SCHEMBL28180925 | 0.99 | PTGS1 (0.98) | PTGS1PDE4ASNCAPDE3APGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108482755-B | Food package sealing machine | 徐州工程学院 | 2020-08-25 | — | — | CN | claimed |
| WO-2016038626-A1 | PHARMACEUTICAL COMPOSITIONS OF VITAMIN KL | EMCURE PHARMACEUTICALS LIMITED (IN) | 2016-03-17 | — | — | WO | claimed |
| US-20150283290-A1 | STERILIZED COMPOSITIONS OF CYANOACRYLATE MONOMERS AND NAPHTHOQUINONE 2,3-OXIDES | ADHEZION BIOMEDICAL, LLC (US) | 2015-10-08 | — | — | US | claimed |
| US-20040122123-A1 | Pultrusion apparatus for continuous fabrication of fiber-reinforced plastic articles having a non-linear shape, methods of fabricating such articles, and compositions used therein | KUSY ROBERT P | 2004-06-24 | — | — | US | claimed |
| US-20020180112-A1 | Pultrusion apparatus for continuous fabrication of fiber-reinforced plastic articles having a non-linear shape, methods of fabricating such articles and compositions used therein | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, THE | 2002-12-05 | — | — | US | claimed |
| US-12295957-B2 | Ascorbic acid and quinone compounds in combination with an antiparasitic agent for treating a parasitic disease | IC-MedTech Corp. (US) | 2025-05-13 | — | — | US | disclosed |
| US-20240398755-A1 | ASCORBIC ACID AND QUINONE COMPOUNDS FOR TREATING CHAGAS DISEASE | IC-MedTech Corp. | 2024-12-05 | — | — | US | disclosed |
| US-12070439-B2 | Phytonadione compositions and related methods | EXELA HOLDINGS, INC. (US) | 2024-08-27 | — | — | US | disclosed |
| CN-117517549-B | Method for simultaneously detecting VK1, MK-4 and MK-7 in milk and application of extractant and reagent combination | 湖南凯莱谱生物科技有限公司 | 2024-06-11 | — | — | CN | disclosed |
| US-11998523-B2 | Ascorbic acid and quinone compounds for treating Chagas disease | IC-MedTech Corp. (US) | 2024-06-04 | — | — | US | disclosed |
| US-20240165084-A1 | ASCORBIC ACID AND QUINONE COMPOUNDS IN COMBINATION WITH AN ANTIPARASITIC AGENT FOR TREATING A PARASITIC DISEASE | IC-MedTech Corp. | 2024-05-23 | — | — | US | disclosed |
| CN-117849233-A | Method for detecting phylloquinone drop related substances | 北京阳光诺和药物研究股份有限公司 | 2024-04-09 | — | — | CN | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| US-4734282-A | Rodenticidal compositions containing 1,4-naphthoquinone derivatives | DUKE UNIVERSITY (US) | 1988-03-29 | — | — | US | disclosed |
| EP-0244309-A2 | Rodenticidal compositions containing 1,4-naphthoquinone derivatives | DUKE UNIVERSITY (US) | 1987-11-04 | — | — | EP | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| EP-0155812-A2 | Dental compositions | KURARAY CO., LTD. (JP) | 1985-09-25 | — | — | EP | disclosed |
| US-4525350-A | Methods of stimulating host defense system with coenzymes Q4 to Q.sub.1 | THE NEW ENGLAND INSTITUTE, INC. (US) | 1985-06-25 | — | — | US | disclosed |
| EP-0117321-A2 | Foodstuffs, including chewing gum with anti-caries activity, and processes for preparing them | TABAGH AG (CH) | 1984-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12070439-B2 | Phytonadione compositions and related methods | UGT2B17, UGT1A10, CYP17A1 | PTGS1 1110/4885PDE4A 1983/4885SNCA 2155/4885 |
| US-20240165084-A1 | ASCORBIC ACID AND QUINONE COMPOUNDS IN COMBINATION WITH AN ANTIPARASITIC AGENT FOR TREATING A PARASITIC DISEASE | NQO1, ADH7, CYP27B1 | PTGS1 2170/4885PDE4A 2540/4885SNCA 587/4885 |
| US-11998523-B2 | Ascorbic acid and quinone compounds for treating Chagas disease | NQO1, ADH7, TALDO1 | PTGS1 2195/4885PDE4A 2261/4885SNCA 715/4885 |
| US-12295957-B2 | Ascorbic acid and quinone compounds in combination with an antiparasitic agent for treating a parasitic disease | NQO1, ADH7, CYP27B1 | PTGS1 2170/4885PDE4A 2540/4885SNCA 587/4885 |
| US-20240398755-A1 | ASCORBIC ACID AND QUINONE COMPOUNDS FOR TREATING CHAGAS DISEASE | NQO1, ADH7, TALDO1 | PTGS1 2195/4885PDE4A 2261/4885SNCA 715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.